Green Cross Wellbeing Corporation

Korea Research Institute of Bioscience and Biotechnology

Green Cross Health Science Co., Ltd.

Jeom Yong Kim

Sun Kyu Park

Min Jung Jang

Young Hyo Yoo

Joo Young Kim

Chang Taek Oh

Min Ju Lim

Su Hwan Lim

Hwan Mook Kim

Sun Young Kim

Bum Woo Park

Ji Duck Kim

Gyoon Hee Han

Jong Hun Lee

Sun Ok Kim

Chang Woo Lee

Jong Hoon Lee

Song Kyu Park

Soo-Hyun Bae

Hee Yoon Lee

Ki Hoon Lee

Jin Hyuk Yang

Dong Kyu Ryu

Tae Gyu Chun

Bong Yong Lee

Jin Ha Lee

Sang Bae Han

Yung Hee Kho

Yi Li

Hyang Woo Lee

Gwan Su Yi

Yoon Hyeok Lee

Jae Cheal Yoo

Su Ae Kim

Jung Hyo Choi

Yong Kee Kim

Kyunga Yu

Jeung Whan Han

Sun-Ok Kim

Young-Hyo Yoo

Nak Hyun Lim

The present invention pertains to aflower water extract composition for preventing or treatinginfection, the composition containing secoxyloganin as an active ingredient. The extract contains a specific amount of secoxyloganin, and thus exhibited excellent antibacterial effects when used onbacteria, and exhibited excellent effects in terms of reducingIgG antibody expression in the blood, alleviating histopathological lesions, and reducing cytokine expression when used on-infected mice. Thus, theflower water extract of the present invention can be usefully used as a composition for preventing or treatinginfection.

flower water extract-containing pharmaceutical composition for preventing or treatinginfection

The present invention relates to a composition for promoting myogenesis, containing, as an active ingredient, a processed ginseng extract in which a trace amount of a ginsenoside ingredient is increased. It has been ascertained that the processed ginseng extract promotes the differentiation of myoblasts into muscle and inhibits muscle atrophy caused by myostatin, which is a myogenesis inhibitory factor, and thus it is expected that a composition for preventing or treating muscle disorder-related diseases, having excellent effects, can be developed.

Composition for promoting myogenesis, containing processed ginseng extract

The present invention relates to a composition for preventing and treating cancer-related fatigue, characterized by containing a new processed ginseng powder or a new processed ginseng extract having an increased amount of a ginsenoside constituent, which was previously minute, by preparing a saponin-decomposing enzyme and subsequently using hydrolysis by the prepared saponin-decomposing enzyme and an organic acid. The composition according to the present invention can be very effectively used for preventing and treating cancer-related fatigue, the most destructive and universal side effect, which is caused by cancer itself or occurs in association with the treatment of cancer.

Composition for reducing cancer cachexia or weight loss caused by anticancer drug therapy or radiation therapy comprising ginseng extract having increased ginsenoside Rg3 and Rh2

A probiotic for inhibiting and preventing the progression of a renal disease and a composition containing the same are disclosed. The probiotic contains a novelBP105 strain, a novelBP121 strain. The novel probiotics, theBP105 strain and theBP121 strain exhibit excellent indoxyl sulfate removal ability, p-cresol removal ability, and phosphorus absorption ability.

Probiotics for inhibiting and preventing progression of renal diseases, and compositions for inhibiting and preventing progression of renal diseases comprising same

Composition for preventing and treating cancer-related fatigue, containing processed ginseng powder or processed ginseng extract having increased ginsenoside constituent

A method for preparing a processed ginseng or a processed ginseng extract having increased contents of ginsenosides Rg3 and Rh2 by (a) inoculating anstrain into a medium composed of ginseng and wheat bran; (b) culturing the strain of step (a); (c) purifying the cultured material of step (b) by ultrafiltration; (d) separating an enzyme from the purified material of step (c); (e) adding the enzyme of step (d) to ginseng or red ginseng; (f) fermenting the ginseng or red ginseng of step (e); (g) separating the fermented material of step (f) to obtain a supernatant; (h) concentrating the supernatant of step (g); (i) reacting the concentrate of step (h) with organic acid; and (j) neutralizing, filtering, purifying, concentrating and drying the reaction product of step (i).

Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased

The present invention is related to novel use of 2-oxo-heterocyclic compounds having anticancer activity and the process for preparing them and a pharmaceutical composition comprising the same. The present invention provides a pharmaceutical composition for preventing and treating the cancer disease comprising lung cancer, bone cancer, pancreatic cancer, skin cancer, cancer of the head and neck, cutaneous or intraocular melanoma, uterine cancer, ovarian cancer, rectal cancer or cancer of the anal region, stomach cancer, colon cancer, breast cancer, gynecologic tumors, Hodgkin's disease, cancer of the esophagus, cancer of the small intestine, cancer of the endocrine system, sarcomas of soft tissues, cancer of the urethra, cancer of the penis, prostate cancer, chronic or acute leukemia, solid tumors of childhood, lymphocytic lymphonas, cancer of the bladder, cancer of the kidney or ureter, or neoplasms of the central nervous system, therefore, it can be used as the therapeutics for treating and preventing cancer diseases.

2-oxo-heterocyclic compounds and pharmaceutical compositions

Growing community of inventors

Seoul, South Korea

Jeom Yong Kim